Zymergen Inc.

From EverybodyWiki Bios & Wiki


Zymergen Inc.
Public
Traded asNASDAQ: ZY
ISIN🆔
IndustryBiotechnology
Founded 📆2013; 9 years ago (2013)
Founders 👔Jed Dean, Josh Hoffman, Zach Serber
Headquarters 🏙️,
Emeryville, California
Area served 🗺️
Key people
Jay Flatley (Chairman & Acting CEO)[1][2]
Steven Chu (Boardmember)[3][4]
Revenue🤑 Increase $19.61 million (2021)[5]
Members
Number of employees
754[6] (2021)
🌐 Websitewww.zymergen.com
📇 Address
📞 telephone

Zymergen is an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research, design, and manufacture genetically modified organisms.

History[edit]

Zymergen was founded in 2013.[7] The company raised $2 million in 2013, $44 million in 2015,[8] $130 million from SoftBank's Vision Fund in 2016,[9] $400 million in 2018,[10] and $300 million in 2020.[11] The company reportedly included DARPA and Fortune 500 companies among its customers by 2016.[12] In 2018, Zymergen acquired fellow biotechnology firm Radiant Genomics.[13]

Zymergen went public in April 2021, but operational problems resulted in a sharp reduction in market capitalization and shareholder lawsuits shortly after.[2] This led to co-founder Josh Hoffman's resignation as CEO and replacement by acting CEO Jay Flatley, who is also currently Zymergen's chairman and Illumina, Inc.'s former CEO.[1]

See also[edit]

  • Ginkgo Bioworks
  • Precigen

References[edit]

  1. 1.0 1.1 Levy, Ari (2021-08-04). "Synthetic biology company Zymergen plunges 68% after saying product revenue will be 'immaterial' in 2022, removing CEO". CNBC. Archived from the original on 2021-08-04. Unknown parameter |url-status= ignored (help)
  2. 2.0 2.1 Feldman, Amy; Au-Yeung, Angel (2021-10-13). "The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO". Forbes. Archived from the original on 2021-10-13. Unknown parameter |url-status= ignored (help)
  3. "Board of Directors". Zymergen.
  4. "ソフトバンク、米バイオVBに投資". 日本経済新聞 (in 日本語). 2016-10-12. Archived from the original on 2016-10-17. Unknown parameter |url-status= ignored (help)
  5. "Zymergen (ZY) Valuation Measures & Financial Statistics". finance.yahoo.com. 2021-12-27.
  6. "Zymergen Inc. (ZY) Company Profile & Facts - Yahoo Finance". finance.yahoo.com. 2021-12-27.
  7. Buhr, Sarah (2015-06-16). "With $44 Million In Funding, Biotech Startup Zymergen Is Buying Up Robots To Mass Produce Materials From Microbes". TechCrunch. Archived from the original on 2015-06-16. Unknown parameter |url-status= ignored (help)
  8. Terry, Mark (2015-12-02). "What You Need to Know About Zymergen". BioSpace. Archived from the original on 2019-05-01. Unknown parameter |url-status= ignored (help)
  9. Buhr, Sarah (2016-10-10). "Biotech startup Zymergen nabs $130 million from Softbank". TechCrunch. Archived from the original on 2016-10-11. Unknown parameter |url-status= ignored (help)
  10. Loizos, Connie (2018-12-13). "Zymergen lands $400 million more, led by SoftBank Vision Fund, for its genetically altered microbes". TechCrunch. Archived from the original on 2018-12-13. Unknown parameter |url-status= ignored (help)
  11. Schieber, Jonathan (2020-09-09). "Zymergen raised $300 million because synthetic biology is so hot right now". TechCrunch. Archived from the original on 2020-09-09. Unknown parameter |url-status= ignored (help)
  12. Konrad, Alex (2016-10-11). "Why SoftBank Just Led A $130 Million Mega Round Into Zymergen's Microbe-Creating Robots". Forbes. Archived from the original on 2016-10-12. Unknown parameter |url-status= ignored (help)
  13. "Zymergen Acquires Radiant Genomics". Genomeweb. 2018-01-08. Archived from the original on 2019-05-14. Unknown parameter |url-status= ignored (help)

External links[edit]


This article "Zymergen" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Zymergen. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.